Fig. 3From: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysisHSROC curve from multi-level bivariate random effects model estimation of diagnostic performance of Pima at CD4 350 cells/μ cut-off¥: plots observed sensitivity and specificity, diagnostic summary point, 95 % confidence and prediction contours.Back to article page